-+ 0.00%
-+ 0.00%
-+ 0.00%

Sanofi forms mature-drugs partnership with Cheplapharm, taking 26.4% stake

PUBT·09/14/2026 13:05:43
Listen to the news
Sanofi forms mature-drugs partnership with Cheplapharm, taking 26.4% stake
  • Sanofi agreed to form a strategic partnership with Cheplapharm covering 20 mature medicines, with Cheplapharm set to acquire three manufacturing sites.
  • Sanofi will take a 26.4% equity stake in Cheplapharm as consideration, deepening a relationship that began in 2014.
  • Assets include Lovenox/Clexane outside the U.S.; the deal supports Sanofi’s shift toward innovation-focused growth.
  • Commercial transfer is expected to start in Q1 2027; the transaction is targeted to close in Q3 2027, subject to approvals.
  • Sanofi expects no impact on its 2026 financial guidance; additional financial terms are to be disclosed later.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sanofi SA published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609140903OMX_____CNEWS_FR_GNW1001262632_fr) on September 14, 2026, and is solely responsible for the information contained therein.